ArticleJournal of cancer research and clinical oncology2024

An analysis of the trends in the usage of Pharmaceutical Benefits Scheme-subsidised cancer drugs in Australia from 2012 to 2022.

Jasmine Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.